MTOR and cancer: Although no molecular mechanism has been characterized for the pleiotropic effects of RARRES1 on cells and cancers of multiple origins, we recently demonstrated that RARRES1 is a novel modulator of glucose dependent de novo lipogenesis and modulates expression of major metabolic regulators, mTOR and SIRT1 [17, 20].